Wuppertal, Germany

Walter Kroh

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 11.0

ph-index = 5

Forward Citations = 130(Granted Patents)


Company Filing History:


Years Active: 2013-2024

Loading Chart...
Loading Chart...
9 patents (USPTO):

Title: The Innovations of Walter Kroh: A Pioneer in Pharmaceutical Patents

Introduction: Walter Kroh, an accomplished inventor based in Wuppertal, Germany, has made significant contributions to the field of pharmaceuticals. With a portfolio of 9 patents, Kroh's work focuses on innovative compounds that have the potential to revolutionize treatment strategies for various diseases.

Latest Patents: Among his latest innovations are the patents for substituted 5-fluoro-1H-pyrazolopyridines. These novel compounds are designed for use in the treatment and prophylaxis of diseases, particularly focusing on cardiovascular disorders. The applications detail processes for their preparation and emphasize their potential in developing medicaments aimed at improving patient outcomes.

Career Highlights: Walter Kroh has held pivotal roles in prominent companies such as Adverio Pharma GmbH and Bayer Intellectual Property GmbH. His experience in these organizations has enabled him to refine his skills in the realm of pharmaceutical research and patent innovation.

Collaborations: Throughout his career, Kroh has collaborated with notable coworkers, including Johannes-Peter Stasch and Gorden Redlich. These partnerships have facilitated the exchange of innovative ideas and advancement in their shared field of expertise.

Conclusion: Walter Kroh's dedication to innovation in the pharmaceutical industry is evident through his patents and collaborative efforts. His research not only contributes to science but also plays a crucial role in the development of new treatment options for patients suffering from cardiovascular diseases and beyond. His work exemplifies the impact that inventors can have on healthcare and medical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…